Mercury Bio

Mercury Bio is a small company based in Santa Fe, New Mexico, with 12 employees. Mercury Bio has developed a drug delivery platform designed to improve the effectiveness of RNA and small-molecule drugs. Their technology focuses on targeted delivery, ensuring that medications reach only the intended cells while minimizing immune reactions. This approach aims to enhance patient outcomes, accelerate drug development timelines, and expand the accessibility of innovative therapies. The company's platform seeks to address the challenges associated with traditional drug delivery systems, including obstacles, delays, and risks. By improving drug efficacy, reducing costs, minimizing side effects, and shortening time to market, Mercury Bio aims to make advanced medications more widely available. For more information about Mercury Bio and their innovative drug delivery solutions, visit their website at mercurybio.com.